Skip to main contentSkip to navigation
Sirius Investors

TRIB Stock: Trinity Biotech plc Stock Price, Analysis & Insights

Get live TRIB stock price $0.66, comprehensive Trinity Biotech plc stock analysis, charts, news, and expert forecast. Real-time TRIB stock data and investment insights.

0.66
2.32%Today
TRIBTrinity Biotech plc • NASDAQ Global Select • Healthcare
Market Cap
6.90M
Volume
150.97K
52W High
3.44
52W Low
0.50

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in Bray, is engaged in the acquisition, development, manufacturing, and global distribution of medical diagnostic solutions. The company's reach extends to the Americas, Afric...

Company Information

CEO
John Gillard
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
380

Contact Information

Address
IDA Business Park
Country
IE

Investment Analysis & Business Insights

Healthcare
Medical - Diagnostics & Research

Investment Highlights

Strong presence in the Healthcare sector with established market position

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Trinity Biotech plc shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Trinity Biotech plc
  • Investors should consider how Trinity Biotech plc fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

6.90M

P/E Ratio (TTM)

-0.33

Beta

0.93

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.